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Aneuploidies
Aneuploidies occur frequently in human preimplantation embryos generated by in vitro fertilization (IVF) and involve almost every human chromosome. 7 Cytogenetic analysis reveals that more than 60% of spontaneous abortions at less than 12 weeks are aneuploid. 1 The advantage of comparative genomic hybridization (CGH) is that the copy number of all chromosomes can be determined and preimplantation genetic diagnosis (PGD) can enable selection of chromosomally normal embryos, thereby improving the IVF implantation rate. 2, 6 This test can also be performed early enough to prevent the freeze/thaw cycle during a normal round of IVF. 3, 4 Preimplantation genetic diagnosis provided the first opportunity for chromosomal analysis of embryos produced by fertile couples. Most of the reliable data that has been collected thus far has been obtained using fluorescent in situ hybridization (FISH) to detect specific chromosomes in interphase nuclei. Fluorescent in situ hybridization is FDA approved as a class 2 device with special controls. Now, a technique has been developed based on whole genome amplification and comparative genomic hybridization (CGH) which allows the copy number of every chromosome to be assessed in almost every cell of a cleavage-stage embryo. 1 Comparative genomic hybridization is a molecular cytogenetic technique in which fluorescently labeled patient and control whole genomic DNA is hybridized to normal metaphase slides. 8 Differential hybridization signals allow the detection of unbalanced gains and losses of chromosomal material across the whole genome at a resolution of approximately 3 to 10 Mb. 9 The application of single cell CGH to each cell of a human preimplantation embryo provides the first opportunity to assess the copy number of all chromosomes and, thus, the genuine abnormality and mosaicism level at this stage of development. Such a method would be useful in gauging levels of aneuploidy and mosaicism in preimplantation embryos; however, published CGH protocols require 0.2 to 1.0 µg of sample DNA, whereas a single cell contains only 6 pg. This problem is overcome by using degenerate oligonucleotide primed polymerase chain reaction (DOP-PCR) for whole genome amplification prior to CGH analysis. 1,2 Whole genome amplification kits are available through Qiagen (Valencia, CA), Sigma (St. Louis, MO), and Rubicon Genomics (Ann Arbor, MI).
Degenerate oligonucleotide primed-PCR yields sufficient quantities of DNA for more than 100 PCR experiments and provides 100% accurate aneuploidy detection. Degenerate oligonucleotide primed-PCR for whole genome amplification (WGA) is carried out using published DOP primers in a traditional PCR reaction. 2 Then, a small portion of the reaction 
Abstract
As molecular diagnostic testing becomes routine in the clinical laboratory, access to comprehensive care is becoming available to a much wider patient demographic. The tests described in this review can be applied to many couples seeking preimplantation genetic diagnosis for common genetic problems. Along with the wide range of applications, these tests can be quickly and easily added to a laboratory's test menu without purchasing new instrumentation or reagents, and most laboratory personnel are already trained in these common techniques. Comparative genomic hybridization can determine chromosome copy number, thereby allowing for selection of chromosomally normal embryos. Polymerase chain reaction (PCR), combined with capillary electrophoresis testing for cystic fibrosis, can be applied to an increasing number of patients using parental haplotype microsatellite detection and implantation of carrier and unaffected embryos. b-thalassemia can be detected by common PCR techniques using established primers. Only homozygous embryos are excluded from transfer. Duchenne muscular dystrophy can also be detected in embryos by PCR-based methods along with sex determination allowing for all female and unaffected male embryos to be transferred. The novelty of each of these tests is that each can be performed on 1 biopsied blastomere in time for the embryo in question to be implanted in the same in vitro fertilization (IVF) cycle, preventing the potentially dangerous freeze and thaw of quality embryos. Here, we review 4 molecular diagnostic assays that are suitable for implementation in the clinical laboratory.
After reading this article, readers should be able to identify 4 common genetic defects leading couples to seek preimplantation genetic diagnosis and the molecular tests that may provide healthy embryos for implantation. Also, readers should understand the limitations that may hinder the progress of implementing these new tests in the clinical laboratory.
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